0001209191-18-035591.txt : 20180605 0001209191-18-035591.hdr.sgml : 20180605 20180605160655 ACCESSION NUMBER: 0001209191-18-035591 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180601 FILED AS OF DATE: 20180605 DATE AS OF CHANGE: 20180605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FITZGERALD EDWARD M CENTRAL INDEX KEY: 0001242993 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38137 FILM NUMBER: 18881171 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001662524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472608175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 55 CAMBRIDGE PARKWAY STREET 2: SUITE 100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 760-603-2732 MAIL ADDRESS: STREET 1: 2855 GAZELLE CT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-01 0 0001662524 AKCEA THERAPEUTICS, INC. AKCA 0001242993 FITZGERALD EDWARD M C/O AKCEA THERAPEUTICS, INC. 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142 1 0 0 0 Stock Option (right to buy) 23.46 2018-06-01 4 A 0 26400 0.00 A 2028-05-31 Common Stock 26400 26400 D The shares vest over a four year period in equal annual installments beginning on June 1, 2018. /s/ Jeffrey Goldberg, Attorney-in-Fact 2018-06-01